Skip to main content

Meghan Laszlo

Sep 24, 2026

19:57
She says she's seeing more patients remain on GLP-1 medications After a cancer diagnosis.
20:03
Initially, when I was seeing patients come in on a DLP one that then had a cancer diagnosis after starting it, most of them are taken off the DLP one right away.
20:16
And that was became the practice.
20:17
And I work mostly in gastrointestinal oncology.
20:21
But what I've seen now is that a lot of folks are staying on them, that there might actually be secondary benefits to being on them during treatment.
20:29
But there's a lot of variation in the dose that somebody's on and how much it's affecting their body and their eating habits.
20:37
And so maybe their dose is lowered.
22:41
particularly when some of that lost weight is muscle.
19:57
She says she's seeing more patients remain on GLP-1 medications After a cancer diagnosis.
20:03
Initially, when I was seeing patients come in on a DLP one that then had a cancer diagnosis after starting it, most of them are taken off the DLP one right away.
20:16
And that was became the practice.
20:17
And I work mostly in gastrointestinal oncology.
20:21
But what I've seen now is that a lot of folks are staying on them, that there might actually be secondary benefits to being on them during treatment.
20:29
But there's a lot of variation in the dose that somebody's on and how much it's affecting their body and their eating habits.
20:37
And so maybe their dose is lowered.
22:41
particularly when some of that lost weight is muscle.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.